Subcutaneous fluid administration

 

Introduction

This procedure involves the administration of a sterile injectable fluid into the subcutaneous tissue. Fairly large amounts of fluid may be introduced into the body in this way; solutions may include dextrose and some electrolytes. Fluids administered subcutaneously are very well absorbed systemically so sometimes remove the need for intravenous infusions. Subcutaneous fluid administration is also referred to as hypodermoclysis, (Ferry et al 1999).

 

Indications

Subcutaneous infusions, (SCIs) may be used to replace lost body fluids and salts after haemorrhage, burns or diarrhoea and vomiting. In addition hydration may be maintained in patients at risk from dehydration due to factors such as an inability to swallow or reduced levels of consciousness. Dehydration is associated with complications such as confusion, urinary tract infection, chest infection and an increased risk of pressure sore formation so prevention is very important. The thickening of the blood in dehydration may lead to an increased risk of thromboembolic disorders such as stroke, deep venous thrombosis and myocardial infarction. Pyrexial patients lose more fluids than those who are apyrexial so this should always be replaced.

 

Solutions of amino acids may also be given by subcutaneous infusions in patients who are unable to eat normally during a period of illness. Analgesics such as morphine may be also be given by SCI, (Coyle and Adelhardt 1996)

 

Advantages

SCIs are perhaps under used in care of the elderly as they have the advantage of maintaining a healthy fluid and nutritional status without the complications associated with intravenous therapy. Complications of intravenous therapy include haemorrhage, extravasation, (tissuing), air embolism, thrombosis, bacteraemia and septicaemia. SCIs require minimal skill to set up and remove. Because the infusion rate is relatively slow complications of over hydration such as pulmonary oedema are unlikely to occur, (Abdulla and Keast 1997). Thoughtful siting will allow patients to retain freedom of movement.  Elderly patients may be difficult to cannulate intravenously, in addition iv and attempted iv cannulation will damage peripheral veins.

 

Potential complications

Harmless localised oedema is the most common complication but will always resolve when the infusion is slowed down or removed. The risk of infection is minimised with good technique. Infusions should always include saline to prevent the levels of salt in the blood dropping. Potassium in high concentrations may cause local necrosis but it is safe to give up to 2 g of Potassium Chloride per litre of solution, (Ferry et al 1999).  The risk of damaging a blood vessel is slight but if blood does appear in the tubing the infusion should be re - sited with a new needle, any bleeding should be arrested with direct pressure. Pain is rare and usually related to the needle penetrating underlying muscle. A correctly sited needle will be able to move freely between the skin and the underling muscle. Pain may also be caused if the flow rate is too high.  While the likelihood of changes in plasma electrolyte concentrations are less than with intravenous infusions this aspect of care should still be considered.

 

Practical aspects

The chosen site should be cleaned using an alcohol impregnated swab and the alcohol allowed time to dry. The area should be swabbed in one direction only so bacteria are removed in the sebum and not simply redistributed over the site. The butterfly cannula used may be a 19 or 21 gauge, this is connected onto the end of the giving set which is then primed. The infusion fluid should also prime the cannula giving tubing and needle. The needle is then inserted into the subcutaneous layer, normally at an angle of about 45 degrees to the surface of the skin, (Farrand and Campbell 1996). In thinner patients it may be necessary to pinch up the area of skin first, but if this is done the actual insertion site should not be touched. The needle of the butterfly should be fully inserted. As the needle insertion site is technically a wound it should be covered with a dressing, this will seal the wound and stabilise the butterfly. A transparent dressing is needed as it is important to observe the site for features of possible inflammation. The infusion may then be started.

 

Strict use of asepsis is vital. The risk of local infection should be minimised by changing the administration needle daily. Mansfield et al (1998) recommended changing the site every 24 hours and the giving set at least every 72 hours. The most common sites used are the abdomen or the chest, usually below the breasts in women. The area over the scapular may also be used.

 

The procedure should be appropriately documented with a note taken of when cannula and giving sets need to be changed. The overall fluid balance of the patient should also be recorded. A well hydrated patient will produce at least 1500 mls of urine per day.

 

Infusion rates

Normally up to 1.5 L per day will be infused per site. Two sites may be used to give a total of 3 L per day. As much as one litre over 8 hours is tolerated well by most patients if required. Abdulla and Keast (1997) advised an infusion rate of 125ml/hour. The practitioner has some latitude with infusion rates depending on their assessment of the local and systemic condition of the patient. The rate of absorption of administered fluid may be increased by the addition of the enzyme hyaluronidase, but this is not essential.

 

Conclusion

SCIs are a safe and effective way to treat and prevent dehydration and so prevent complications. They may be used in hospitals or at home and are often the kindest method for the patient and are less demanding on staff and finances.

 

References

 

 

Abdulla A.  Keast J.  Hypodermoclysis as a means of rehydration.

Nursing Times.  93(29):54-5, 1997 Jul 16-22.

 

Coyle N.  Adelhardt J. Cancer patients and subcutaneous infusions.

American Journal of Nursing.  96(3):61, 1996 Mar.

 

Farrand S.  Campbell AJ.  Safe, simple subcutaneous fluid administration.

British Journal of Hospital Medicine.  55(11):690-2, 1996 Jun 5-18.

 

Ferry M.  Dardaine V.  Constans T.  Subcutaneous infusion or hypodermoclysis: a practical approach. Journal of the American Geriatrics Society.  47(1):93-5, 1999 Jan.

 

Mansfield S.  Monaghan H.  Hall J.  Subcutaneous fluid administration and site maintenance. Nursing Standard.  13(12):56, 59-62, 1998 Dec 9-15.